When insiders sell significant portions of their holdings, it often sends a mixed signal to the market. In early November 2025, B. Lynne Parshall, a director at Cytokinetics, Incorporated (NASDAQ:CYTK), disposed of 5,000 shares in an open-market transaction, reducing her direct stake by 17.9%.